NorthWest Biotherapeutics Inc (NWBO)

[photonic5]

Yes. They’re late in a P3 trial that had promising interim results published in May. Heavily diluted share count. Little cash. Unblinded results on primary and secondary endpoints expected very soon. Data could sink this biotech or send it to the stars. I recommend only the hardest of liquors for investors here. This investment takes nerves of steel and patience. Sometimes there is good information on this board, but most of it is talk around the poker table. We’re gambling here on results, but the flop and the turn look good. River card has yet to fall.